Auxly Cannabis Group Inc
OTC:CBWTF

Watchlist Manager
Auxly Cannabis Group Inc Logo
Auxly Cannabis Group Inc
OTC:CBWTF
Watchlist
Price: 0.1086 USD -0.37% Market Closed
Market Cap: 136.1m USD

EV/EBIT
Enterprise Value to EBIT

-10.2
Current
-2.6
Median
16.7
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-10.2
=
Enterprise Value
193.7m CAD
/
EBIT
-18.9m CAD
EBIT Growth EV/EBIT to Growth
CA
Auxly Cannabis Group Inc
OTC:CBWTF
Average EV/EBIT: 1 870.3
Negative Multiple: -10.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
28.2
33%
0.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
18.5
14%
1.3
CH
Roche Holding AG
SIX:ROG
10.4
6%
1.7
UK
AstraZeneca PLC
LSE:AZN
168.4
23%
7.3
CH
Novartis AG
SIX:NOVN
13.5
10%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
14%
0.7
US
Merck & Co Inc
NYSE:MRK
9.5
9%
1.1
IE
E
Endo International PLC
LSE:0Y5F
731.8
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
9%
1.1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-28.5
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A